Middle East Complementary And Alternative Medicine Market Size, Share & Trends Analysis Report By Intervention (Traditional Alternative Medicine/Botanicals, Body Healing), By Application, By Distribution Channel, By Country, And Segment Forecasts, 2024 - 2030
This report can be delivered to the clients within 3 Business Days
Middle East Complementary And Alternative Medicine Market Growth & Trends
The Middle East complementary and alternative medicine market size is expected t%li%reach USD 51.40 billion by 2030, expanding at a CAGR of 22.77% from 2024 t%li%2030, according t%li%a new report by Grand View Research, Inc. Complementary and alternative medicines (CAM) include remedies or treatments that are used instead of or as supplements with conventional allopathic treatments. The various types of complementary and alternative medicines include remedies based on traditional alternative medicine & botanicals, mind-healing techniques, body-healing therapies, external energy, and sensory healing.
The Middle Eastern region and its cultures offer lucrative opportunities t%li%players in the complementary and alternative medicine market, owing t%li%a history of commonly practiced spiritual healing techniques and herbal medicine, such as Unani, for the treatment of several disorders. As a result, traditional practitioners are a vital part of disease management in the region. Traditional alternative medicines and botanicals include naturopathic medicine, traditional Chinese medicine, and traditional Arabic medicine.
Due t%li%the increasing burden of chronic diseases and the rising popularity of alternative medicines, several new healing centers are being launched in this space in the Middle East. For instance, in July 2021, the Lootah Group of Companies, in partnership with Kerala's Santhigiri Group, launched the Santhigiri Holistic Healthcare Centre in Dubai, which offers a range of complementary and alternative medicine varieties such as acupuncture, homeopathy, chiropractic, and yoga. Such centers are likely t%li%boost the market over the forecast period.
The Middle East region has witnessed significant social and economic impact due t%li%the coronavirus pandemic. The government authorities in this region are keen on promoting the use of traditional alternatives in COVID-19 treatment, however, it is imperative t%li%cater t%li%the conventional research standards devised for all the other drug candidates. In addition, in the recent past, WHO has als%li%acknowledged and stated that CAM exhibits several benefits, that may assist in the effective, safe, and maximum at-home management of COVID-19 symptoms.
Furthermore, an increase in the geriatric population in the region is expected t%li%boost the market growth in the region. According t%li%WHO, in 2050, 80% of older people (above 60) will be living in low- and middle-income countries. Commonly, older people are increasingly choosing CAM treatments, especially acupuncture, herbal products, bloodletting, medical massage, cauterization, and religious rituals. In addition, certain disease conditions such as back pain, insomnia, Alzheimer’s disease, and colds are associated with the use of complementary and alternative medicine among older people.
On the other hand, key challenges faced by the Middle Eastern population using complementary and alternative medicine, are the lack of well-documented data pertaining t%li%the efficacy of CAM therapeutic interventions, lack of robust support from doctors, physicians, and professionals toward incorporation of CAM in conventional treatment options, and fewer number of CAM training programs. However various conferences are being held in the region on complementary and alternative medicine t%li%overcome the challenges associated t%li%CAM therapies. For instance, CAM therapies 2022 conference organized by Pulsus is scheduled on the fifth and sixth of December in Dubai, UAE. Such platforms in the region are helping t%li%share, promote and encourage advancements in complementary & alternative medicine.
Middle East Complementary And Alternative Medicine Market Report Highlights
Middle East Complementary And Alternative Medicine Market Growth & Trends
The Middle East complementary and alternative medicine market size is expected t%li%reach USD 51.40 billion by 2030, expanding at a CAGR of 22.77% from 2024 t%li%2030, according t%li%a new report by Grand View Research, Inc. Complementary and alternative medicines (CAM) include remedies or treatments that are used instead of or as supplements with conventional allopathic treatments. The various types of complementary and alternative medicines include remedies based on traditional alternative medicine & botanicals, mind-healing techniques, body-healing therapies, external energy, and sensory healing.
The Middle Eastern region and its cultures offer lucrative opportunities t%li%players in the complementary and alternative medicine market, owing t%li%a history of commonly practiced spiritual healing techniques and herbal medicine, such as Unani, for the treatment of several disorders. As a result, traditional practitioners are a vital part of disease management in the region. Traditional alternative medicines and botanicals include naturopathic medicine, traditional Chinese medicine, and traditional Arabic medicine.
Due t%li%the increasing burden of chronic diseases and the rising popularity of alternative medicines, several new healing centers are being launched in this space in the Middle East. For instance, in July 2021, the Lootah Group of Companies, in partnership with Kerala's Santhigiri Group, launched the Santhigiri Holistic Healthcare Centre in Dubai, which offers a range of complementary and alternative medicine varieties such as acupuncture, homeopathy, chiropractic, and yoga. Such centers are likely t%li%boost the market over the forecast period.
The Middle East region has witnessed significant social and economic impact due t%li%the coronavirus pandemic. The government authorities in this region are keen on promoting the use of traditional alternatives in COVID-19 treatment, however, it is imperative t%li%cater t%li%the conventional research standards devised for all the other drug candidates. In addition, in the recent past, WHO has als%li%acknowledged and stated that CAM exhibits several benefits, that may assist in the effective, safe, and maximum at-home management of COVID-19 symptoms.
Furthermore, an increase in the geriatric population in the region is expected t%li%boost the market growth in the region. According t%li%WHO, in 2050, 80% of older people (above 60) will be living in low- and middle-income countries. Commonly, older people are increasingly choosing CAM treatments, especially acupuncture, herbal products, bloodletting, medical massage, cauterization, and religious rituals. In addition, certain disease conditions such as back pain, insomnia, Alzheimer’s disease, and colds are associated with the use of complementary and alternative medicine among older people.
On the other hand, key challenges faced by the Middle Eastern population using complementary and alternative medicine, are the lack of well-documented data pertaining t%li%the efficacy of CAM therapeutic interventions, lack of robust support from doctors, physicians, and professionals toward incorporation of CAM in conventional treatment options, and fewer number of CAM training programs. However various conferences are being held in the region on complementary and alternative medicine t%li%overcome the challenges associated t%li%CAM therapies. For instance, CAM therapies 2022 conference organized by Pulsus is scheduled on the fifth and sixth of December in Dubai, UAE. Such platforms in the region are helping t%li%share, promote and encourage advancements in complementary & alternative medicine.
Middle East Complementary And Alternative Medicine Market Report Highlights
- By intervention, the traditional alternative medicine and botanicals segment held the dominant share owing t%li%a history of commonly practiced spiritual healing techniques and herbal medicine, such as Unani, for the treatment of several disorders
- By application, the stress, anxiety, and depression segment dominates the market in 2023. Due t%li%the rapid increase in lifestyle-associated changes, growing geopolitical pressures, and the resultant rise in mental health-associated conditions in the region
- By distribution channel, the direct distribution segment held a larger share in 2023. This is attributed t%li%the high rates of self-prescribed use of complementary and alternative medicine products, particularly botanicals and traditional medicines
- Saudi Arabia dominated the global market in 2023 due t%li%the growing popularity of CAM coupled with the presence of government bodies is expected t%li%drive market growth in Saudi Arabia
- The UAE is projected t%li%grow considerably in the future due t%li%the increasing popularity of CAM in the country. For instance, according t%li%a survey conducted by DHCC (Dubai Healthcare City), around 48% of the country’s people tried CAM and around 55% were happy with the results
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Intervention
1.2.2. Application
1.2.3. Distribution Channel
1.2.4. Regional scope
1.2.5. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Treatment and application outlook
2.2.2. Distribution channel outlook
2.2.3. Regional outlook
2.3. Competitive Insights
CHAPTER 3. MIDDLE EAST COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Growing awareness about wellness medicine
3.2.1.2. Growing recognition and coverage
3.2.1.3. Government initiatives and changing regulatory status
3.2.1.4. Demographic changes driving the demand
3.2.2. Market restraint analysis
3.2.2.1. Lack of clinical data
3.2.2.2. Lack of insurance coverage
3.3. Middle East Complementary And Alternative Medicine Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
3.4. Regulatory and Reimbursement Scenario
3.5. Consumer Behavior Analysis
CHAPTER 4. MIDDLE EAST COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET: TREATMENT ESTIMATES & TREND ANALYSIS
4.1. Middle East Complementary And Alternative Medicine Market: Intervention Dashboard
4.2. Middle East Complementary And Alternative Medicine Market: Intervention Movement Analysis
4.3. Middle East Complementary And Alternative Medicine Market by Intervention, (USD Million), 2018 - 2030
4.4. Traditional Alternative Medicine/Botanicals
4.4.1. Traditional alternative medicine/botanicals market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.2. Ayurveda
4.4.2.1. Ayurveda market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.3. Traditional Arabic medicine
4.4.3.1. Traditional Arabic medicine market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.4. Naturopathic Medicine
4.4.4.1. Naturopathic medicine market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.5. Homeopathy
4.4.5.1. Homeopathy market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.6. Others
4.4.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Mind Healing
4.5.1. Mind healing market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.2. Transcendental meditation
4.5.2.1. Transcendental meditation market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.3. Neuro-linguistic programming
4.5.3.1. Neuro-linguistic programming market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.4. Others
4.5.4.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
4.6. Body Healing
4.6.1. Body healing market estimates and forecasts, 2018 to 2030 (USD Million)
4.6.2. Yoga
4.6.2.1. Yoga market estimates and forecasts, 2018 to 2030 (USD Million)
4.6.3. Chiropractic
4.6.3.1. Chiropractic market estimates and forecasts, 2018 to 2030 (USD Million)
4.6.4. Acupuncture
4.6.4.1. Acupuncture market estimates and forecasts, 2018 to 2030 (USD Million)
4.6.5. Kinesiology
4.6.5.1. Kinesiology market estimates and forecasts, 2018 to 2030 (USD Million)
4.6.6. Reflexology
4.6.6.1. Reflexology market estimates and forecasts, 2018 to 2030 (USD Million)
4.6.7. Others
4.6.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
4.7. External Energy
4.7.1. External energy market estimates and forecasts, 2018 to 2030 (USD Million)
4.7.2. Electromagnetic therapy
4.7.2.1. Electromagnetic therapy market estimates and forecasts, 2018 to 2030 (USD Million)
4.7.3. Reiki
4.7.3.1. Reiki market estimates and forecasts, 2018 to 2030 (USD Million)
4.7.4. Chakra
4.7.4.1. Chakra market estimates and forecasts, 2018 to 2030 (USD Million)
4.8. Sensory Healing
4.8.1. Sensory healing market estimates and forecasts, 2018 to 2030 (USD Million)
4.8.2. Aromatherapy
4.8.2.1. Aromatherapy market estimates and forecasts, 2018 to 2030 (USD Million)
4.8.3. Sound Healing
4.8.3.1. Sound healing market estimates and forecasts, 2018 to 2030 (USD Million)
CHAPTER 5. MIDDLE EAST COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET: APPLICATION ESTIMATES & TREND ANALYSIS
5.1. Middle East Complementary And Alternative Medicine Market: Application Dashboard
5.2. Middle East Complementary And Alternative Medicine Market: Application Movement Analysis
5.3. Middle East Complementary And Alternative Medicine Market Estimates and Forecasts, By Application, (USD Million), 2018 - 2030
5.4. Stress, Anxiety, and Depression
5.4.1. Stress, anxiety, and depression market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Cardiovascular Diseases
5.5.1. Hormonal therapy market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. Diabetes
5.6.1. Diabetes market estimates and forecasts, 2018 to 2030 (USD Million)
5.7. Obesity
5.7.1. Obesity market estimates and forecasts, 2018 to 2030 (USD Million)
5.8. Infertility
5.8.1. Infertility market estimates and forecasts, 2018 to 2030 (USD Million)
5.9. Others
5.9.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
CHAPTER 6. MIDDLE EAST COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET: DISTRIBUTION CHANNEL ESTIMATES & TREND ANALYSIS
6.1. Middle East Complementary And Alternative Medicine Market: Distribution Channel Dashboard
6.2. Middle East Complementary And Alternative Medicine Market: Distribution Channel Movement Analysis
6.3. Middle East Complementary And Alternative Medicine Market Estimates and Forecasts by Distribution Channel, (USD Million), 2018 - 2030
6.4. Direct Distribution
6.4.1. Direct distribution market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. E-Distribution
6.5.1. E-distribution channel market estimates and forecasts, 2018 to 2030 (USD Million)
CHAPTER 7. MIDDLE EAST COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET: REGIONAL ESTIMATES & TREND ANALYSIS BY INTERVENTION, APPLICATION, DISTRIBUTION CHANNEL
7.1. Regional Dashboard
7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030
7.2.1. Saudi Arabia
7.2.1.1. Key country dynamics
7.2.1.2. Regulatory framework/ reimbursement structure
7.2.1.3. Competitive scenario
7.2.1.4. Saudi Arabia market estimates and forecasts, 2018 to 2030 (USD Million)
7.2.2. South Africa
7.2.2.1. Key country dynamics
7.2.2.2. Regulatory framework/ reimbursement structure
7.2.2.3. Competitive scenario
7.2.2.4. South Africa market estimates and forecasts, 2018 to 2030 (USD Million)
7.2.3. Mexico
7.2.3.1. Key country dynamics
7.2.3.2. Regulatory framework/ reimbursement structure
7.2.3.3. Competitive scenario
7.2.3.4. Mexico market estimates and forecasts, 2018 to 2030 (USD Million)
7.2.4. Egypt
7.2.4.1. Key country dynamics
7.2.4.2. Regulatory framework/ reimbursement structure
7.2.4.3. Competitive scenario
7.2.4.4. Egypt market estimates and forecasts, 2018 to 2030 (USD Million)
7.2.5. UAE
7.2.5.1. Key country dynamics
7.2.5.2. Regulatory framework/ reimbursement structure
7.2.5.3. Competitive scenario
7.2.5.4. UAE market estimates and forecasts, 2018 to 2030 (USD Million)
7.2.6. Israel
7.2.6.1. Key country dynamics
7.2.6.2. Regulatory framework/ reimbursement structure
7.2.6.3. Competitive scenario
7.2.6.4. Israel market estimates and forecasts, 2018 to 2030 (USD Million)
7.2.7. Oman
7.2.7.1. Key country dynamics
7.2.7.2. Regulatory framework/ reimbursement structure
7.2.7.3. Competitive scenario
7.2.7.4. Oman market estimates and forecasts, 2018 to 2030 (USD Million)
7.2.8. Kuwait
7.2.8.1. Key country dynamics
7.2.8.2. Regulatory framework/ reimbursement structure
7.2.8.3. Competitive scenario
7.2.8.4. Kuwait market estimates and forecasts, 2018 to 2030 (USD Million)
7.2.9. Qatar
7.2.9.1. Key country dynamics
7.2.9.2. Regulatory framework/ reimbursement structure
7.2.9.3. Competitive scenario
7.2.9.4. Qatar market estimates and forecasts, 2018 to 2030 (USD Million)
7.2.10. Bahrain
7.2.10.1. Key country dynamics
7.2.10.2. Regulatory framework/ reimbursement structure
7.2.10.3. Competitive scenario
7.2.10.4. Bahrain market estimates and forecasts, 2018 to 2030 (USD Million)
CHAPTER 8. COMPETITIVE LANDSCAPE
8.1. Company/Competition Categorization
8.2. Vendor Landscape
8.2.1. List of key distributors and channel partners
8.2.2. Key customers
8.2.3. Key company market share analysis, 2023
8.2.4. Arab Yoga Foundation
8.2.4.1. Company overview
8.2.4.2. Financial performance
8.2.4.3. Product benchmarking
8.2.4.4. Strategic initiatives
8.2.5. Soul Warrior
8.2.5.1. Company overview
8.2.5.2. Financial performance
8.2.5.3. Product benchmarking
8.2.5.4. Strategic initiatives
8.2.6. Sukoon Yoga Center.
8.2.6.1. Company overview
8.2.6.2. Financial performance
8.2.6.3. Product benchmarking
8.2.6.4. Strategic initiatives
8.2.7. Halo Aura
8.2.7.1. Company overview
8.2.7.2. Financial performance
8.2.7.3. Product benchmarking
8.2.7.4. Strategic initiatives
8.2.8. InTouch Clinic
8.2.8.1. Company overview
8.2.8.2. Financial performance
8.2.8.3. Product benchmarking
8.2.8.4. Strategic initiatives
8.2.9. Landmark Fitness Limited
8.2.9.1. Company overview
8.2.9.2. Financial performance
8.2.9.3. Product benchmarking
8.2.9.4. Strategic initiatives
8.2.10. Osana
8.2.10.1. Company overview
8.2.10.2. Financial performance
8.2.10.3. Product benchmarking
8.2.10.4. Strategic initiatives
8.2.11. Erada Center for Treatment and Rehab
8.2.11.1. Company overview
8.2.11.2. Financial performance
8.2.11.3. Product benchmarking
8.2.11.4. Strategic initiatives
8.2.12. Bluetreelinics.com.
8.2.12.1. Company overview
8.2.12.2. Financial performance
8.2.12.3. Product benchmarking
8.2.12.4. Strategic initiatives
8.2.13. House of Nature Medical Center LLC
8.2.13.1. Company overview
8.2.13.2. Financial performance
8.2.13.3. Product benchmarking
8.2.13.4. Strategic initiatives
8.2.14. Zen Yoga
8.2.14.1. Company overview
8.2.14.2. Financial performance
8.2.14.3. Product benchmarking
8.2.14.4. Strategic initiatives
8.2.15. Earthy Center
8.2.15.1. Company overview
8.2.15.2. Financial performance
8.2.15.3. Product benchmarking
8.2.15.4. Strategic initiatives
8.2.16. German Medical Center FZ-LLC
8.2.16.1. Company overview
8.2.16.2. Financial performance
8.2.16.3. Product benchmarking
8.2.16.4. Strategic initiatives
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Intervention
1.2.2. Application
1.2.3. Distribution Channel
1.2.4. Regional scope
1.2.5. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Treatment and application outlook
2.2.2. Distribution channel outlook
2.2.3. Regional outlook
2.3. Competitive Insights
CHAPTER 3. MIDDLE EAST COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Growing awareness about wellness medicine
3.2.1.2. Growing recognition and coverage
3.2.1.3. Government initiatives and changing regulatory status
3.2.1.4. Demographic changes driving the demand
3.2.2. Market restraint analysis
3.2.2.1. Lack of clinical data
3.2.2.2. Lack of insurance coverage
3.3. Middle East Complementary And Alternative Medicine Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
3.4. Regulatory and Reimbursement Scenario
3.5. Consumer Behavior Analysis
CHAPTER 4. MIDDLE EAST COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET: TREATMENT ESTIMATES & TREND ANALYSIS
4.1. Middle East Complementary And Alternative Medicine Market: Intervention Dashboard
4.2. Middle East Complementary And Alternative Medicine Market: Intervention Movement Analysis
4.3. Middle East Complementary And Alternative Medicine Market by Intervention, (USD Million), 2018 - 2030
4.4. Traditional Alternative Medicine/Botanicals
4.4.1. Traditional alternative medicine/botanicals market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.2. Ayurveda
4.4.2.1. Ayurveda market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.3. Traditional Arabic medicine
4.4.3.1. Traditional Arabic medicine market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.4. Naturopathic Medicine
4.4.4.1. Naturopathic medicine market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.5. Homeopathy
4.4.5.1. Homeopathy market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.6. Others
4.4.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Mind Healing
4.5.1. Mind healing market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.2. Transcendental meditation
4.5.2.1. Transcendental meditation market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.3. Neuro-linguistic programming
4.5.3.1. Neuro-linguistic programming market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.4. Others
4.5.4.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
4.6. Body Healing
4.6.1. Body healing market estimates and forecasts, 2018 to 2030 (USD Million)
4.6.2. Yoga
4.6.2.1. Yoga market estimates and forecasts, 2018 to 2030 (USD Million)
4.6.3. Chiropractic
4.6.3.1. Chiropractic market estimates and forecasts, 2018 to 2030 (USD Million)
4.6.4. Acupuncture
4.6.4.1. Acupuncture market estimates and forecasts, 2018 to 2030 (USD Million)
4.6.5. Kinesiology
4.6.5.1. Kinesiology market estimates and forecasts, 2018 to 2030 (USD Million)
4.6.6. Reflexology
4.6.6.1. Reflexology market estimates and forecasts, 2018 to 2030 (USD Million)
4.6.7. Others
4.6.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
4.7. External Energy
4.7.1. External energy market estimates and forecasts, 2018 to 2030 (USD Million)
4.7.2. Electromagnetic therapy
4.7.2.1. Electromagnetic therapy market estimates and forecasts, 2018 to 2030 (USD Million)
4.7.3. Reiki
4.7.3.1. Reiki market estimates and forecasts, 2018 to 2030 (USD Million)
4.7.4. Chakra
4.7.4.1. Chakra market estimates and forecasts, 2018 to 2030 (USD Million)
4.8. Sensory Healing
4.8.1. Sensory healing market estimates and forecasts, 2018 to 2030 (USD Million)
4.8.2. Aromatherapy
4.8.2.1. Aromatherapy market estimates and forecasts, 2018 to 2030 (USD Million)
4.8.3. Sound Healing
4.8.3.1. Sound healing market estimates and forecasts, 2018 to 2030 (USD Million)
CHAPTER 5. MIDDLE EAST COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET: APPLICATION ESTIMATES & TREND ANALYSIS
5.1. Middle East Complementary And Alternative Medicine Market: Application Dashboard
5.2. Middle East Complementary And Alternative Medicine Market: Application Movement Analysis
5.3. Middle East Complementary And Alternative Medicine Market Estimates and Forecasts, By Application, (USD Million), 2018 - 2030
5.4. Stress, Anxiety, and Depression
5.4.1. Stress, anxiety, and depression market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Cardiovascular Diseases
5.5.1. Hormonal therapy market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. Diabetes
5.6.1. Diabetes market estimates and forecasts, 2018 to 2030 (USD Million)
5.7. Obesity
5.7.1. Obesity market estimates and forecasts, 2018 to 2030 (USD Million)
5.8. Infertility
5.8.1. Infertility market estimates and forecasts, 2018 to 2030 (USD Million)
5.9. Others
5.9.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
CHAPTER 6. MIDDLE EAST COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET: DISTRIBUTION CHANNEL ESTIMATES & TREND ANALYSIS
6.1. Middle East Complementary And Alternative Medicine Market: Distribution Channel Dashboard
6.2. Middle East Complementary And Alternative Medicine Market: Distribution Channel Movement Analysis
6.3. Middle East Complementary And Alternative Medicine Market Estimates and Forecasts by Distribution Channel, (USD Million), 2018 - 2030
6.4. Direct Distribution
6.4.1. Direct distribution market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. E-Distribution
6.5.1. E-distribution channel market estimates and forecasts, 2018 to 2030 (USD Million)
CHAPTER 7. MIDDLE EAST COMPLEMENTARY AND ALTERNATIVE MEDICINE MARKET: REGIONAL ESTIMATES & TREND ANALYSIS BY INTERVENTION, APPLICATION, DISTRIBUTION CHANNEL
7.1. Regional Dashboard
7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030
7.2.1. Saudi Arabia
7.2.1.1. Key country dynamics
7.2.1.2. Regulatory framework/ reimbursement structure
7.2.1.3. Competitive scenario
7.2.1.4. Saudi Arabia market estimates and forecasts, 2018 to 2030 (USD Million)
7.2.2. South Africa
7.2.2.1. Key country dynamics
7.2.2.2. Regulatory framework/ reimbursement structure
7.2.2.3. Competitive scenario
7.2.2.4. South Africa market estimates and forecasts, 2018 to 2030 (USD Million)
7.2.3. Mexico
7.2.3.1. Key country dynamics
7.2.3.2. Regulatory framework/ reimbursement structure
7.2.3.3. Competitive scenario
7.2.3.4. Mexico market estimates and forecasts, 2018 to 2030 (USD Million)
7.2.4. Egypt
7.2.4.1. Key country dynamics
7.2.4.2. Regulatory framework/ reimbursement structure
7.2.4.3. Competitive scenario
7.2.4.4. Egypt market estimates and forecasts, 2018 to 2030 (USD Million)
7.2.5. UAE
7.2.5.1. Key country dynamics
7.2.5.2. Regulatory framework/ reimbursement structure
7.2.5.3. Competitive scenario
7.2.5.4. UAE market estimates and forecasts, 2018 to 2030 (USD Million)
7.2.6. Israel
7.2.6.1. Key country dynamics
7.2.6.2. Regulatory framework/ reimbursement structure
7.2.6.3. Competitive scenario
7.2.6.4. Israel market estimates and forecasts, 2018 to 2030 (USD Million)
7.2.7. Oman
7.2.7.1. Key country dynamics
7.2.7.2. Regulatory framework/ reimbursement structure
7.2.7.3. Competitive scenario
7.2.7.4. Oman market estimates and forecasts, 2018 to 2030 (USD Million)
7.2.8. Kuwait
7.2.8.1. Key country dynamics
7.2.8.2. Regulatory framework/ reimbursement structure
7.2.8.3. Competitive scenario
7.2.8.4. Kuwait market estimates and forecasts, 2018 to 2030 (USD Million)
7.2.9. Qatar
7.2.9.1. Key country dynamics
7.2.9.2. Regulatory framework/ reimbursement structure
7.2.9.3. Competitive scenario
7.2.9.4. Qatar market estimates and forecasts, 2018 to 2030 (USD Million)
7.2.10. Bahrain
7.2.10.1. Key country dynamics
7.2.10.2. Regulatory framework/ reimbursement structure
7.2.10.3. Competitive scenario
7.2.10.4. Bahrain market estimates and forecasts, 2018 to 2030 (USD Million)
CHAPTER 8. COMPETITIVE LANDSCAPE
8.1. Company/Competition Categorization
8.2. Vendor Landscape
8.2.1. List of key distributors and channel partners
8.2.2. Key customers
8.2.3. Key company market share analysis, 2023
8.2.4. Arab Yoga Foundation
8.2.4.1. Company overview
8.2.4.2. Financial performance
8.2.4.3. Product benchmarking
8.2.4.4. Strategic initiatives
8.2.5. Soul Warrior
8.2.5.1. Company overview
8.2.5.2. Financial performance
8.2.5.3. Product benchmarking
8.2.5.4. Strategic initiatives
8.2.6. Sukoon Yoga Center.
8.2.6.1. Company overview
8.2.6.2. Financial performance
8.2.6.3. Product benchmarking
8.2.6.4. Strategic initiatives
8.2.7. Halo Aura
8.2.7.1. Company overview
8.2.7.2. Financial performance
8.2.7.3. Product benchmarking
8.2.7.4. Strategic initiatives
8.2.8. InTouch Clinic
8.2.8.1. Company overview
8.2.8.2. Financial performance
8.2.8.3. Product benchmarking
8.2.8.4. Strategic initiatives
8.2.9. Landmark Fitness Limited
8.2.9.1. Company overview
8.2.9.2. Financial performance
8.2.9.3. Product benchmarking
8.2.9.4. Strategic initiatives
8.2.10. Osana
8.2.10.1. Company overview
8.2.10.2. Financial performance
8.2.10.3. Product benchmarking
8.2.10.4. Strategic initiatives
8.2.11. Erada Center for Treatment and Rehab
8.2.11.1. Company overview
8.2.11.2. Financial performance
8.2.11.3. Product benchmarking
8.2.11.4. Strategic initiatives
8.2.12. Bluetreelinics.com.
8.2.12.1. Company overview
8.2.12.2. Financial performance
8.2.12.3. Product benchmarking
8.2.12.4. Strategic initiatives
8.2.13. House of Nature Medical Center LLC
8.2.13.1. Company overview
8.2.13.2. Financial performance
8.2.13.3. Product benchmarking
8.2.13.4. Strategic initiatives
8.2.14. Zen Yoga
8.2.14.1. Company overview
8.2.14.2. Financial performance
8.2.14.3. Product benchmarking
8.2.14.4. Strategic initiatives
8.2.15. Earthy Center
8.2.15.1. Company overview
8.2.15.2. Financial performance
8.2.15.3. Product benchmarking
8.2.15.4. Strategic initiatives
8.2.16. German Medical Center FZ-LLC
8.2.16.1. Company overview
8.2.16.2. Financial performance
8.2.16.3. Product benchmarking
8.2.16.4. Strategic initiatives
LIST OF TABLES
Table 1 List of abbreviation
Table 2 Saudi Arabia Middle East complementary and alternative medicine market, By intervention, 2018 - 2030 (USD Million)
Table 3 Saudi Arabia Middle East complementary and alternative medicine market, By application, 2018 - 2030 (USD Million)
Table 4 Saudi Arabia Middle East complementary and alternative medicine market, By distribution channel, 2018 - 2030 (USD Million)
Table 5 South Africa Middle East complementary and alternative medicine market, By intervention, 2018 - 2030 (USD Million)
Table 6 South Africa Middle East complementary and alternative medicine market, By application, 2018 - 2030 (USD Million)
Table 7 South Africa Middle East complementary and alternative medicine market, By distribution channel, 2018 - 2030 (USD Million)
Table 8 UAE Middle East complementary and alternative medicine market, By intervention, 2018 - 2030 (USD Million)
Table 9 UAE Middle East complementary and alternative medicine market, By application, 2018 - 2030 (USD Million)
Table 10 UAE Middle East complementary and alternative medicine market, By distribution channel, 2018 - 2030 (USD Million)
Table 11 Egypt Middle East complementary and alternative medicine market, By intervention, 2018 - 2030 (USD Million)
Table 12 Egypt Middle East complementary and alternative medicine market, By application, 2018 - 2030 (USD Million)
Table 13 Egypt Middle East complementary and alternative medicine market, By distribution channel, 2018 - 2030 (USD Million)
Table 14 Israel Middle East complementary and alternative medicine market, By intervention, 2018 - 2030 (USD Million)
Table 15 Israel Middle East complementary and alternative medicine market, By application, 2018 - 2030 (USD Million)
Table 16 Israel Middle East complementary and alternative medicine market, By distribution channel, 2018 - 2030 (USD Million)
Table 17 Oman Middle East complementary and alternative medicine market, By intervention, 2018 - 2030 (USD Million)
Table 18 Oman Middle East complementary and alternative medicine market, By application, 2018 - 2030 (USD Million)
Table 19 Oman Middle East complementary and alternative medicine market, By distribution channel, 2018 - 2030 (USD Million)
Table 20 Kuwait Middle East complementary and alternative medicine market, By intervention, 2018 - 2030 (USD Million)
Table 21 Kuwait Middle East complementary and alternative medicine market, By application, 2018 - 2030 (USD Million)
Table 22 Kuwait Middle East complementary and alternative medicine market, By distribution channel, 2018 - 2030 (USD Million)
Table 23 Qatar Middle East complementary and alternative medicine market, By intervention, 2018 - 2030 (USD Million)
Table 24 Qatar Middle East complementary and alternative medicine market, By application, 2018 - 2030 (USD Million)
Table 25 Qatar Middle East complementary and alternative medicine market, By distribution channel, 2018 - 2030 (USD Million)
Table 26 Bahrain Middle East complementary and alternative medicine market, By intervention, 2018 - 2030 (USD Million)
Table 27 Bahrain Middle East complementary and alternative medicine market, By Application, 2018 - 2030 (USD Million)
Table 28 Bahrain Middle East complementary and alternative medicine market, By distribution channel, 2018 - 2030 (USD Million)
Table 1 List of abbreviation
Table 2 Saudi Arabia Middle East complementary and alternative medicine market, By intervention, 2018 - 2030 (USD Million)
Table 3 Saudi Arabia Middle East complementary and alternative medicine market, By application, 2018 - 2030 (USD Million)
Table 4 Saudi Arabia Middle East complementary and alternative medicine market, By distribution channel, 2018 - 2030 (USD Million)
Table 5 South Africa Middle East complementary and alternative medicine market, By intervention, 2018 - 2030 (USD Million)
Table 6 South Africa Middle East complementary and alternative medicine market, By application, 2018 - 2030 (USD Million)
Table 7 South Africa Middle East complementary and alternative medicine market, By distribution channel, 2018 - 2030 (USD Million)
Table 8 UAE Middle East complementary and alternative medicine market, By intervention, 2018 - 2030 (USD Million)
Table 9 UAE Middle East complementary and alternative medicine market, By application, 2018 - 2030 (USD Million)
Table 10 UAE Middle East complementary and alternative medicine market, By distribution channel, 2018 - 2030 (USD Million)
Table 11 Egypt Middle East complementary and alternative medicine market, By intervention, 2018 - 2030 (USD Million)
Table 12 Egypt Middle East complementary and alternative medicine market, By application, 2018 - 2030 (USD Million)
Table 13 Egypt Middle East complementary and alternative medicine market, By distribution channel, 2018 - 2030 (USD Million)
Table 14 Israel Middle East complementary and alternative medicine market, By intervention, 2018 - 2030 (USD Million)
Table 15 Israel Middle East complementary and alternative medicine market, By application, 2018 - 2030 (USD Million)
Table 16 Israel Middle East complementary and alternative medicine market, By distribution channel, 2018 - 2030 (USD Million)
Table 17 Oman Middle East complementary and alternative medicine market, By intervention, 2018 - 2030 (USD Million)
Table 18 Oman Middle East complementary and alternative medicine market, By application, 2018 - 2030 (USD Million)
Table 19 Oman Middle East complementary and alternative medicine market, By distribution channel, 2018 - 2030 (USD Million)
Table 20 Kuwait Middle East complementary and alternative medicine market, By intervention, 2018 - 2030 (USD Million)
Table 21 Kuwait Middle East complementary and alternative medicine market, By application, 2018 - 2030 (USD Million)
Table 22 Kuwait Middle East complementary and alternative medicine market, By distribution channel, 2018 - 2030 (USD Million)
Table 23 Qatar Middle East complementary and alternative medicine market, By intervention, 2018 - 2030 (USD Million)
Table 24 Qatar Middle East complementary and alternative medicine market, By application, 2018 - 2030 (USD Million)
Table 25 Qatar Middle East complementary and alternative medicine market, By distribution channel, 2018 - 2030 (USD Million)
Table 26 Bahrain Middle East complementary and alternative medicine market, By intervention, 2018 - 2030 (USD Million)
Table 27 Bahrain Middle East complementary and alternative medicine market, By Application, 2018 - 2030 (USD Million)
Table 28 Bahrain Middle East complementary and alternative medicine market, By distribution channel, 2018 - 2030 (USD Million)
LIST OF FIGURES
Fig. 1 Healthcare contract development and manufacturing organization market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Data analysis models
Fig. 5 Market formulation and validation
Fig. 6 Data validating & publishing
Fig. 7 Commodity flow analysis
Fig. 8 Market snapshot
Fig. 9 Segment snapshot
Fig. 10 Segment snapshot
Fig. 11 Competitive landscape snapshot
Fig. 12 Parent market outlook, 2023 (USD Billion)
Fig. 13 Ancillary market outlook, 2023 (USD Billion)
Fig. 14 Healthcare contract development and manufacturing organization market dynamics
Fig. 15 Porter’s five forces analysis
Fig. 16 PESTEL analysis
Fig. 17 Healthcare contract development and manufacturing organization market : Services outlook and key takeaways
Fig. 18 Healthcare contract development and manufacturing organization market : Services movement analysis
Fig. 19 Contract Development market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 Small Molecule market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 Preclinical market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Bioanalysis and DMPK Studies market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Toxicology Testing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Other Preclinical Services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Clinical market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Phase I market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Phase II market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 Phase III market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Phase IV market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Laboratory Services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Bioanalytical Services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Analytical Services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 33 Large Molecule market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 34 Cell Line development market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 35 Process Development market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 Upstream market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 37 Microbial market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 38 Mammalian market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 39 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 40 Downstream market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 41 MABs market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 42 Recombinant Proteins market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 43 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 44 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 45 Contract Manufacturing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 46 Small Molecule market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 47 Large Molecule market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 48 MABs market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 49 Recombinant Proteins market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 50 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 51 High Potency API market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 52 Finished Dose Formulations market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 53 Solid Dose Formulation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 54 Liquid Dose Formulation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 55 Injectable Dose Formulation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 56 Medical Devices market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 57 Class I market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 58 Class II market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 59 Class III market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 60 Regional market: Key takeaways
Fig. 61 Regional outlook, 2023 & 2030
Fig. 62 Regional outlook, 2023 & 2030
Fig. 63 North America Healthcare contract development and manufacturing organization market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 64 Key country dynamics
Fig. 65 U.S. Healthcare contract development and manufacturing organization market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 66 Key country dynamics
Fig. 67 Canada Healthcare contract development and manufacturing organization market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 68 Key country dynamics
Fig. 69 Germany Healthcare contract development and manufacturing organization market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 70 Key country dynamics
Fig. 71 UK Healthcare contract development and manufacturing organization market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 72 Key country dynamics
Fig. 73 France Healthcare contract development and manufacturing organization market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 74 Key country dynamics
Fig. 75 Italy Healthcare contract development and manufacturing organization market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 76 Key country dynamics
Fig. 77 Spain Healthcare contract development and manufacturing organization market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 78 Key country dynamics
Fig. 79 Netherlands Healthcare contract development and manufacturing organization market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 80 Key country dynamics
Fig. 81 Belgium Healthcare contract development and manufacturing organization market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 82 Key country dynamics
Fig. 83 Denmark Healthcare contract development and manufacturing organization market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 84 Key country dynamics
Fig. 85 Norway Healthcare contract development and manufacturing organization market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 86 Key country dynamics
Fig. 87 Sweden Healthcare contract development and manufacturing organization market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 88 Key country dynamics
Fig. 89 China Healthcare contract development and manufacturing organization market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 90 Key country dynamics
Fig. 91 India Healthcare contract development and manufacturing organization market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 92 Key country dynamics
Fig. 93 Japan Healthcare contract development and manufacturing organization market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 94 Key country dynamics
Fig. 95 Australia Healthcare contract development and manufacturing organization market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 96 Key country dynamics
Fig. 97 South Korea Healthcare contract development and manufacturing organization market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 98 Key country dynamics
Fig. 99 Malaysia Healthcare contract development and manufacturing organization market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 100 Key country dynamics
Fig. 101 New Zealand Healthcare contract development and manufacturing organization market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 102 Key country dynamics
Fig. 103 Singapore Healthcare contract development and manufacturing organization market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 104 Key country dynamics
Fig. 105 Philippines Healthcare contract development and manufacturing organization market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 106 Key country dynamics
Fig. 107 Thailand Healthcare contract development and manufacturing organization market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 108 Key country dynamics
Fig. 109 Brazil Healthcare contract development and manufacturing organization market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 110 Key country dynamics
Fig. 111 Mexico Healthcare contract development and manufacturing organization market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 112 Key country dynamics
Fig. 113 Argentina Healthcare contract development and manufacturing organization market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 114 Key country dynamics
Fig. 115 Colombia Healthcare contract development and manufacturing organization market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 116 Key country dynamics
Fig. 117 Chile Healthcare contract development and manufacturing organization market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 118 Key country dynamics
Fig. 119 South Africa Healthcare contract development and manufacturing organization market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 120 Key country dynamics
Fig. 121 Saudi Arabia Healthcare contract development and manufacturing organization market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 122 Key country dynamics
Fig. 123 UAE Healthcare contract development and manufacturing organization market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 124 Key country dynamics
Fig. 125 Israel Healthcare contract development and manufacturing organization market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 126 Key country dynamics
Fig. 127 Kuwait Healthcare contract development and manufacturing organization market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 1 Healthcare contract development and manufacturing organization market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Data analysis models
Fig. 5 Market formulation and validation
Fig. 6 Data validating & publishing
Fig. 7 Commodity flow analysis
Fig. 8 Market snapshot
Fig. 9 Segment snapshot
Fig. 10 Segment snapshot
Fig. 11 Competitive landscape snapshot
Fig. 12 Parent market outlook, 2023 (USD Billion)
Fig. 13 Ancillary market outlook, 2023 (USD Billion)
Fig. 14 Healthcare contract development and manufacturing organization market dynamics
Fig. 15 Porter’s five forces analysis
Fig. 16 PESTEL analysis
Fig. 17 Healthcare contract development and manufacturing organization market : Services outlook and key takeaways
Fig. 18 Healthcare contract development and manufacturing organization market : Services movement analysis
Fig. 19 Contract Development market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 Small Molecule market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 Preclinical market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Bioanalysis and DMPK Studies market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Toxicology Testing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Other Preclinical Services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Clinical market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Phase I market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Phase II market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 Phase III market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Phase IV market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Laboratory Services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Bioanalytical Services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Analytical Services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 33 Large Molecule market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 34 Cell Line development market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 35 Process Development market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 Upstream market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 37 Microbial market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 38 Mammalian market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 39 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 40 Downstream market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 41 MABs market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 42 Recombinant Proteins market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 43 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 44 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 45 Contract Manufacturing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 46 Small Molecule market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 47 Large Molecule market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 48 MABs market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 49 Recombinant Proteins market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 50 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 51 High Potency API market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 52 Finished Dose Formulations market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 53 Solid Dose Formulation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 54 Liquid Dose Formulation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 55 Injectable Dose Formulation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 56 Medical Devices market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 57 Class I market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 58 Class II market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 59 Class III market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 60 Regional market: Key takeaways
Fig. 61 Regional outlook, 2023 & 2030
Fig. 62 Regional outlook, 2023 & 2030
Fig. 63 North America Healthcare contract development and manufacturing organization market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 64 Key country dynamics
Fig. 65 U.S. Healthcare contract development and manufacturing organization market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 66 Key country dynamics
Fig. 67 Canada Healthcare contract development and manufacturing organization market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 68 Key country dynamics
Fig. 69 Germany Healthcare contract development and manufacturing organization market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 70 Key country dynamics
Fig. 71 UK Healthcare contract development and manufacturing organization market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 72 Key country dynamics
Fig. 73 France Healthcare contract development and manufacturing organization market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 74 Key country dynamics
Fig. 75 Italy Healthcare contract development and manufacturing organization market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 76 Key country dynamics
Fig. 77 Spain Healthcare contract development and manufacturing organization market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 78 Key country dynamics
Fig. 79 Netherlands Healthcare contract development and manufacturing organization market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 80 Key country dynamics
Fig. 81 Belgium Healthcare contract development and manufacturing organization market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 82 Key country dynamics
Fig. 83 Denmark Healthcare contract development and manufacturing organization market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 84 Key country dynamics
Fig. 85 Norway Healthcare contract development and manufacturing organization market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 86 Key country dynamics
Fig. 87 Sweden Healthcare contract development and manufacturing organization market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 88 Key country dynamics
Fig. 89 China Healthcare contract development and manufacturing organization market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 90 Key country dynamics
Fig. 91 India Healthcare contract development and manufacturing organization market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 92 Key country dynamics
Fig. 93 Japan Healthcare contract development and manufacturing organization market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 94 Key country dynamics
Fig. 95 Australia Healthcare contract development and manufacturing organization market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 96 Key country dynamics
Fig. 97 South Korea Healthcare contract development and manufacturing organization market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 98 Key country dynamics
Fig. 99 Malaysia Healthcare contract development and manufacturing organization market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 100 Key country dynamics
Fig. 101 New Zealand Healthcare contract development and manufacturing organization market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 102 Key country dynamics
Fig. 103 Singapore Healthcare contract development and manufacturing organization market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 104 Key country dynamics
Fig. 105 Philippines Healthcare contract development and manufacturing organization market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 106 Key country dynamics
Fig. 107 Thailand Healthcare contract development and manufacturing organization market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 108 Key country dynamics
Fig. 109 Brazil Healthcare contract development and manufacturing organization market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 110 Key country dynamics
Fig. 111 Mexico Healthcare contract development and manufacturing organization market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 112 Key country dynamics
Fig. 113 Argentina Healthcare contract development and manufacturing organization market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 114 Key country dynamics
Fig. 115 Colombia Healthcare contract development and manufacturing organization market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 116 Key country dynamics
Fig. 117 Chile Healthcare contract development and manufacturing organization market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 118 Key country dynamics
Fig. 119 South Africa Healthcare contract development and manufacturing organization market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 120 Key country dynamics
Fig. 121 Saudi Arabia Healthcare contract development and manufacturing organization market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 122 Key country dynamics
Fig. 123 UAE Healthcare contract development and manufacturing organization market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 124 Key country dynamics
Fig. 125 Israel Healthcare contract development and manufacturing organization market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 126 Key country dynamics
Fig. 127 Kuwait Healthcare contract development and manufacturing organization market estimates and forecasts, 2018 - 2030 (USD Million)
